524606 — Beryl Drugs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Beryl Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12.2	15.6	6.61	9.43	4.71
Net Total Accounts Receivable
Net Total Receivables	45.8	69.2	75.8	54.6	20.9
Total Inventory
Total Other Current Assets
Total Current Assets	106	103	102	90.4	68.3
Net Property, Plant And Equipment	58.6	58.1	59.6	60	68.2
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	178	175	175	160	150
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	84.9	63.3	57.6	43	44.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	105	94.5	85.6	64.6	50.8
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	72.9	80.7	89.2	95	98.9
Total Liabilities & Shareholders' Equity	178	175	175	160	150
Total Common Shares Outstanding